Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark McAllister

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 12, 2020
Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: OrBiTo consortium commentaryMasoud Jamei, Bertil Abrahamsson, Jonathan Brown, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 31, 2013
In vitro models for the prediction of in vivo performance of oral dosage formsEdmund S Kostewicz, Bertil Abrahamsson, Marcus Brewster, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 13, 2013
Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needsChristel A S Bergström, René Holm, Søren Astrup Jørgensen, et al.
Pharmaceutics|May 4, 2026
TIM-1 and Tiny-TIM as Robust In Vitro Models for Oral Biopharmaceutics: Evidence from an International Ring StudyConnor O'Farrell, Robert Havenaar, Mark McAllister, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 4, 2020
Dissolution testing of modified release products with biorelevant media: An OrBiTo ring study using the USP apparatus III and IVChristos Reppas, Napoleon-Nikolaos Vrettos, Jennifer Dressman, et al.
Pharmaceutics|May 28, 2022
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar SeriesMark McAllister, Talia Flanagan, Susan Cole, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 24, 2018
In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaborationJames Butler, Bart Hens, Maria Vertzoni, et al.
Pharmaceutics|May 27, 2026
Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary ReportMark McAllister, Nena Mistry, Xavier Pepin, et al.
Advanced Drug Delivery Reviews|February 21, 2021
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP networkZahari Vinarov, Bertil Abrahamsson, Per Artursson, et al.
Molecular Pharmaceutics|July 1, 2024
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary ReportXavier Pepin, Sumit Arora, Luiza Borges, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 12, 2020
Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: OrBiTo consortium commentaryMasoud Jamei, Bertil Abrahamsson, Jonathan Brown, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 31, 2013
In vitro models for the prediction of in vivo performance of oral dosage formsEdmund S Kostewicz, Bertil Abrahamsson, Marcus Brewster, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 13, 2013
Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needsChristel A S Bergström, René Holm, Søren Astrup Jørgensen, et al.
Pharmaceutics|May 4, 2026
TIM-1 and Tiny-TIM as Robust In Vitro Models for Oral Biopharmaceutics: Evidence from an International Ring StudyConnor O'Farrell, Robert Havenaar, Mark McAllister, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 4, 2020
Dissolution testing of modified release products with biorelevant media: An OrBiTo ring study using the USP apparatus III and IVChristos Reppas, Napoleon-Nikolaos Vrettos, Jennifer Dressman, et al.
Pharmaceutics|May 28, 2022
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar SeriesMark McAllister, Talia Flanagan, Susan Cole, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 24, 2018
In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaborationJames Butler, Bart Hens, Maria Vertzoni, et al.
Pharmaceutics|May 27, 2026
Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary ReportMark McAllister, Nena Mistry, Xavier Pepin, et al.
Advanced Drug Delivery Reviews|February 21, 2021
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP networkZahari Vinarov, Bertil Abrahamsson, Per Artursson, et al.
Molecular Pharmaceutics|July 1, 2024
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary ReportXavier Pepin, Sumit Arora, Luiza Borges, et al.
Pageof 6